ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target - simplywall.st
ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target simplywall.st
Latest articles and price-sensitive announcements with AI sentiment classification.
ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target simplywall.st
ImpediMed (ASX:IPD) FDA Clearance Expands SOZO Opportunity as Commercial Execution Remains Key Kalkine
other announcement
IPD Group Shares Break Higher, Fundamentals Support The Move thebull.com.au


IPD Group lifted FY26 revenue, profit and dividends above guidance. The post IPD Group reports record profits and dividends in FY26 appeared first on The Motley Fool Australia.
other announcement
other announcement
ImpediMed Limited (ASX: IPD) has informed the ASX that 2,635,000 unquoted options (IPDAAB) expired on 30 June 2026 following the lapse of conditional rights. These options, which had varying exercise prices and expiry dates, ceased due to failure to meet the attached conditions. Despite this lapse, the company’s issued capital structure remains largely unchanged, with ordinary shares and other option classes continuing to trade and remain outstanding. Key Highlights ImpediMed Limited (IPD) ...
ImpediMed (ASX:IPD) Posts A$7.5M Revenue—Could This Medtech Stock Be Approaching Inflection Point? Kalkine
director_dealing announcement
director_dealing announcement
other announcement
Highlights A significant insider share purchase has placed ImpediMed back on the radar of market participants. The medical technology company continues to expand the commercial reach of its bioimpedance spectroscopy platform. Strong insider ownership activity has intensified focus on the company's long-term healthcare growth strategy. ImpediMed is drawing renewed attention following major insider buying activity, healthcare technology innovation and expanding opportunities in patient monitori...
Fiona Bones Bought 911% More Shares In ImpediMed simplywall.st
director_dealing announcement
director_dealing announcement
other announcement
other announcement
ImpediMed (ASX:IPD) Advances Funding Plans with Successful Share Purchase Plan Kalkine
capital_raise announcement

Let's take a look at 3 fresh buy, hold, and sell calls from the experts. The post Buy, hold, sell: IPD, Kogan, Rio Tinto shares appeared first on The Motley Fool Australia.
director_dealing announcement
director_dealing announcement

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, … The post Why Contact Energy, IPD, Northern Star, and Tower shares are sinking today appeared first on The Motley Fool Australia.
Highlights IPD Group shares fell sharply after releasing FY26 earnings guidance. The company still expects strong earnings growth across multiple divisions. Markets may be reacting to elevated expectations following a major share price rally. IPD shares fell despite positive guidance as markets reassessed expectations following a major share price rally. IPD Group Ltd (ASX:IPG) shares moved sharply lower on Thursday despite the company delivering guidance that still points toward strong earni...
capital_raise announcement
other announcement
ImpediMed (ASX:IPD) A$15.2m raise buys time for SOZO breakeven Stocks Down Under
other announcement
other announcement
other announcement